STAGE III BREAST CANCER
Clinical trials for STAGE III BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE III BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to train immune system against breast cancer stem cells
⭐️ VACCINE ⭐️ OngoingThis early-phase trial tests a DNA vaccine called STEMVAC in 42 people with advanced HER2-negative breast cancer that is stable or gone after standard treatment. The vaccine is designed to help the immune system recognize and attack cancer stem cells, which are often resistant to…
Matched conditions: STAGE III BREAST CANCER
Phase: PHASE1 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated May 06, 2026 16:14 UTC
-
New hope for aggressive breast cancer: which chemo works best after surgery?
Disease control OngoingThis study tests whether platinum-based chemotherapy (cisplatin or carboplatin) works better than capecitabine in people with a certain type of aggressive breast cancer (triple-negative, basal-like) that still has cancer cells after initial chemotherapy and surgery. About 415 par…
Matched conditions: STAGE III BREAST CANCER
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 09, 2026 07:21 UTC
-
New hope for hard-to-treat breast cancer: immune-boosting combos tested
Disease control OngoingThis study tests whether combining an immunotherapy drug (avelumab) with other targeted drugs can shrink or control advanced triple-negative breast cancer that has spread or come back. About 145 adults with stage IV or inoperable breast cancer are taking part. The goal is to see …
Matched conditions: STAGE III BREAST CANCER
Phase: PHASE2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control
Last updated May 09, 2026 07:21 UTC
-
New hope for breast cancer: Pre-Surgery combo may shrink tumors
Disease control OngoingThis study tests whether giving chemotherapy (paclitaxel and cyclophosphamide) with or without the targeted drug trastuzumab before surgery can shrink breast tumors and reduce the amount of breast tissue that needs to be removed. It includes 92 women with early-stage or locally a…
Matched conditions: STAGE III BREAST CANCER
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 09, 2026 07:18 UTC
-
Can a workout keep cancer away? new study tests exercise as a weapon
Disease control OngoingThis study looks at whether aerobic exercise can lower ctDNA levels in the blood, which may help prevent cancer from returning. About 33 people who have been treated for breast, prostate, or colorectal cancer and are at high risk of relapse will try different amounts of weekly ex…
Matched conditions: STAGE III BREAST CANCER
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
New drug combo shows promise in shrinking aggressive breast tumors before surgery
Disease control OngoingThis study tested a combination of two drugs, T-DM1 and pertuzumab, given before surgery to people with early-stage HER2-positive breast cancer. The goal was to see if this treatment could completely eliminate the tumor by the time of surgery. The study involved 164 participants …
Matched conditions: STAGE III BREAST CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 06, 2026 16:01 UTC